Processa Pharmaceuticals, Inc. Other Notes Payable, Current
Processa Pharmaceuticals, Inc. (PCSA) had Other Notes Payable, Current of $500.00 thousand as of 2013-12-31, per its 10-K filed 2015-04-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:OtherNotesPayableCurrent · last filed 2015-04-14
- 2013-12-31: Other Notes Payable, Current $500.00K.
- 2013-09-30: Other Notes Payable, Current $1.00M.
- 2013-06-30: Other Notes Payable, Current $1.00M.
- 2012-12-31: Other Notes Payable, Current $500.00K.
| Period end | Other Notes Payable, Current |
|---|---|
| 2013-12-31 | $500.00K 10-K · filed 2015-04-14 |
| 2013-09-30 | $1.00M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $1.00M 10-Q/A · filed 2013-09-06 |
| 2012-12-31 | $500.00K 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |